
Quotient Limited QTNT
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited Zahlungsmittel 2011-2026 | QTNT
Zahlungsmittel Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 45.7 M | 3.4 M | 4.1 M | 20.2 M | 4.75 M | 44.1 M | 37.5 M | 7.19 M | 4.22 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 45.7 M | 3.4 M | 19 M |
Zahlungsmittel Vierteljährlich Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.9 M | 24.5 M | 46.2 M | 65.1 M | 85.1 M | 121 M | 115 M | 115 M | 3.4 M | 3.4 M | 18.1 M | 7.32 M | 4.66 M | 4.66 M | 5.82 M | 6.53 M | 4.47 M | 4.47 M | 3.56 M | 20.2 M | 6.15 M | 9.13 M | 13 M | 4.75 M | 14.3 M | 19 M | 22.4 M | 44.1 M | 24.1 M | 25.7 M | 21.3 M | 37.5 M | 33 M | 17.1 M | 32 M | 7.19 M | 13.8 M | 1.54 M | 1.74 M | 4.22 M | - | - | - | 4.35 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 121 M | 1.54 M | 25 M |
Zahlungsmittel anderer Aktien in der Diagnostik & Forschung
| Name | Zahlungsmittel | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
1.48 B | $ 118.25 | -1.27 % | $ 35.9 B | ||
|
Burning Rock Biotech Limited
BNR
|
1.9 B | $ 22.5 | 9.44 % | $ 242 M | ||
|
Check-Cap Ltd.
CHEK
|
7.7 M | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
65.4 M | $ 22.42 | 27.6 % | $ 1.19 B | ||
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
11.9 M | $ 1.46 | 2.82 % | $ 1.94 M | ||
|
Castle Biosciences
CSTL
|
120 M | $ 24.56 | -0.24 % | $ 682 M | ||
|
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
214 M | $ 176.94 | -2.0 % | $ 8.77 B | ||
|
Medpace Holdings
MEDP
|
497 M | $ 515.65 | -0.56 % | $ 14.9 B | ||
|
Danaher Corporation
DHR
|
4.62 B | $ 193.78 | -2.18 % | $ 138 B | ||
|
Interpace Biosciences
IDXG
|
2.5 M | $ 2.2 | - | $ 9.73 M | ||
|
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | ||
|
NeoGenomics
NEO
|
160 M | $ 8.16 | -5.99 % | $ 1.05 B | ||
|
Neogen Corporation
NEOG
|
129 M | $ 9.24 | -1.91 % | $ 2 B | ||
|
Illumina
ILMN
|
1.13 B | $ 132.72 | 0.35 % | $ 21.1 B | ||
|
Fulgent Genetics
FLGT
|
55.1 M | $ 16.13 | -0.25 % | $ 488 M | ||
|
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 28.63 | -1.58 % | $ 20 B | ||
|
Guardant Health
GH
|
378 M | $ 85.7 | 0.99 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
1.24 M | $ 2.83 | -3.41 % | $ 91.8 K | ||
|
Biomerica
BMRA
|
2.4 M | $ 2.2 | 4.27 % | $ 5.05 M | ||
|
Senseonics Holdings
SENS
|
40.2 M | $ 6.77 | -1.88 % | $ 282 M | ||
|
ICON Public Limited Company
ICLR
|
752 M | $ 115.58 | -0.79 % | $ 9.53 B | ||
|
Laboratory Corporation of America Holdings
LH
|
532 M | $ 266.36 | -0.14 % | $ 22.2 B | ||
|
Soleno Therapeutics
SLNO
|
70.1 M | $ 52.57 | - | $ 2.67 B | ||
|
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | ||
|
Celcuity
CELC
|
166 M | $ 125.25 | 1.44 % | $ 5.86 B | ||
|
Neuronetics
STIM
|
28.1 M | $ 1.4 | 0.72 % | $ 92.3 M | ||
|
Myriad Genetics
MYGN
|
150 M | $ 5.0 | -3.66 % | $ 463 M | ||
|
Lantheus Holdings
LNTH
|
359 M | $ 83.92 | -0.02 % | $ 5.66 B | ||
|
Thermo Fisher Scientific
TMO
|
9.85 B | $ 516.0 | -2.95 % | $ 195 B | ||
|
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.7 | -0.54 % | $ 61.9 M | ||
|
Quest Diagnostics Incorporated
DGX
|
420 M | $ 191.46 | 0.02 % | $ 21.3 B | ||
|
ENDRA Life Sciences
NDRA
|
762 K | $ 5.17 | 0.58 % | $ 4.07 M | ||
|
Twist Bioscience Corporation
TWST
|
183 M | $ 56.23 | -2.41 % | $ 3.36 B |